Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 57.9 TWD -3.66% Market Closed
Market Cap: 15.3B TWD

Intrinsic Value

The intrinsic value of one Tanvex BioPharma Inc stock under the Base Case scenario is 8.25 TWD. Compared to the current market price of 57.9 TWD, Tanvex BioPharma Inc is Overvalued by 86%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
8.25 TWD
Overvaluation 86%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tanvex BioPharma Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about Tanvex BioPharma Inc?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Tanvex BioPharma Inc valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tanvex BioPharma Inc.

Explain Valuation
Compare Tanvex BioPharma Inc to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tanvex BioPharma Inc?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tanvex BioPharma Inc

Current Assets 2.1B
Receivables 165m
Other Current Assets 1.9B
Non-Current Assets 6.1B
Long-Term Investments 200m
PP&E 2.4B
Intangibles 3.3B
Other Non-Current Assets 227m
Current Liabilities 694m
Accounts Payable 60m
Accrued Liabilities 119m
Other Current Liabilities 515m
Non-Current Liabilities 1.5B
Long-Term Debt 1.4B
Other Non-Current Liabilities 106m
Efficiency

Free Cash Flow Analysis
Tanvex BioPharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tanvex BioPharma Inc

Revenue
224.5m TWD
Cost of Revenue
-420.4m TWD
Gross Profit
-195.9m TWD
Operating Expenses
-1.1B TWD
Operating Income
-1.3B TWD
Other Expenses
-16m TWD
Net Income
-1.4B TWD
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tanvex BioPharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Tanvex BioPharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tanvex BioPharma Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
48/100
Solvency
Score

Tanvex BioPharma Inc's solvency score is 48/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tanvex BioPharma Inc

There are no price targets for Tanvex BioPharma Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Tanvex BioPharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Tanvex BioPharma Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Tanvex BioPharma Inc stock?

The intrinsic value of one Tanvex BioPharma Inc stock under the Base Case scenario is 8.25 TWD.

Is Tanvex BioPharma Inc stock undervalued or overvalued?

Compared to the current market price of 57.9 TWD, Tanvex BioPharma Inc is Overvalued by 86%.

Back to Top